货号 | 16271-25mg |
描述 | The immunoproteasome is a specialized, inducible proteasome that generates peptides presented on major histocompatibility complex (MHC) class I molecules to cytotoxic T cells. Stimulation of cells with inflammatory cytokines such as IFN-γ leads to the replacement of constitutive catalytic proteasome β subunits with inducible β subunits (β1i (LMP2), β2i (MECL1), and β5i (LMP7)), which are required for the production of certain MHC class I-restricted T cell epitopes. ONX 0914 is a selective inhibitor of the β5i (LMP7) subunit of the immunoproteasome (IC50s = 65 and 73 nM for mouse and human, respectively) and demonstrates significantly weaker activity at the β5 subunit of the constitutive proteasome (IC50s = 0.92 and 1.04 µM for mouse and human, respectively).1,2 It can block the production of IL-23 by activated monocytes and the production of IFN-γ and IL-2 by T cells.1 ONX 0914 can also inhibit IL-17-producing T cells under TH17-polarizing conditions in vitro and reduce TH1 and TH17 cell differentiation in vivo.3 This compound has been shown to attenuate disease progression in several experimental models of autoimmune disorders as well as in some hematologic malignancies.1,4,5,6 |
别名 | PR-957; |
供应商 | Cayman |
应用文献 | |
1.Muchamuel, T.,Basler, M.,Aujay, M.A., et al. A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nature Medicine 15(7), 781-787 (2009). 2.Huber, E.M.,Basler, M.,Schwab, R., et al. Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity. Cell 148(4), 727-738 (2012). 3.Kalim, K.W.,Basler, M.,Kirk, C.J., et al. Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation. Journal of Immunology 189(8), 4182-4193 (2012). 4.Basler, M.,Daiee, M.,Moll, C., et al. Prevention of experimental colitis by a selective inhibitor of the immunoproteasome. Journal of Immunology 185(1), 634-641 (2010). 5.Niewerth, D.,Franke, N.E.,Jansen, G., et al. Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitors. Haematologica 98(12), 1896-1904 (2013). 6.Niewerth, D.,Kaspers, G.J.,Assaraf, Y.G., et al. Interferon-γ-induced upregulation of immunoproteasome subunit assembly overcomes bortezomib resistance in human hematological cell lines. J.Hematol.Oncol. 7(1), 1-15 (2014). | |
运输条件 | Room temperature in continental US; may vary elsewhere |
存放说明 | -20 |
纯度 | ≥98% |
计算分子量 | 580.7 |
分子式 | C31H40N4O7 |
CAS号 | 960374-59-8 |
稳定性 | ≥ 2 years |
本官网所有报价均为常温或者蓝冰运输价格,如有产品需要干冰运输,需另外加收干冰运输费。 |